Metastatic Gastric Cancer Clinical Trials

50 clinical trials for Metastatic Gastric Cancer across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer — RECRUITING · PHASE2
• Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer — RECRUITING · PHASE4
• A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. — RECRUITING · PHASE1
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer — RECRUITING · PHASE2
• Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma — RECRUITING · PHASE2
• Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer — RECRUITING · NA
• First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) — RECRUITING · PHASE2
• Liver Embolization Approaches for Tumor Management — RECRUITING
• Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer — RECRUITING · PHASE2
• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy — COMPLETED · NA
• Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) — COMPLETED · PHASE2
• 89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study — COMPLETED · NA
• A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors — TERMINATED · PHASE1
• Study of OB-002 in Patients With Refractory Metastatic Cancer — WITHDRAWN · PHASE1
• WaKING: Wnt and checKpoint INhibition in Gastric Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer — ACTIVE_NOT_RECRUITING
• Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial — COMPLETED · PHASE2
• International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer — OTHER
• TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer — COMPLETED · PHASE1
• GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study — COMPLETED · PHASE1
• INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701 — WITHDRAWN · PHASE2
• Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer — OTHER · PHASE2
• Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer — OTHER · PHASE1
• Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers — COMPLETED · PHASE1
• Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer — OTHER · NA
• Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects — COMPLETED · PHASE1
• Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — OTHER · PHASE1
• Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma — COMPLETED · PHASE2
• Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer — NOT_YET_RECRUITING · PHASE3
• Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer — OTHER · PHASE3
• Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer — OTHER · PHASE2
• The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer — OTHER · PHASE2
• Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction — OTHER · PHASE2
• Genotype Guided Chemotherapy in Gastric Cancer Patients — COMPLETED · PHASE2
• Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer — TERMINATED · PHASE3
• Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric Cancer — COMPLETED · NA
• Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer — OTHER
• Resistance to Immunotherapy in Gastric Cancer — OTHER
• Metronomic Chemotherapy in Advanced Gastric Cancer — OTHER · PHASE2
• An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer — OTHER
• A Trial of RAD001/Capecitabine in Refractory Gastric Cancer — COMPLETED · PHASE1
• Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer — COMPLETED · PHASE2
• Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer — COMPLETED · PHASE2
• Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008) — TERMINATED · PHASE2
• The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel — OTHER

Refine this search